Lexaria Bioscience Corp. (LEXX) — Institutional Holders, Q2 2026
31 institutional investment managers reported a LEXX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $920.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
LEXX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSAdded · +143,432 sh+$80.3K
- VANGUARD CAPITAL MANAGEMENTAdded · +76,143 sh+$42.6K
- HRT FINANCIALAdded · +46,584 sh+$26.1K
- StoneX GroupNew · +25,714 sh+$14.4K
- NORTHERNAdded · +21,436 sh+$12.0K
Biggest sellers
- Invenomic Capital ManagementTrimmed · -96,616 sh-$54.1K
- GEODE CAPITAL MANAGEMENTTrimmed · -43,742 sh-$24.5K
- TORONTO DOMINION BANKTrimmed · -40,000 sh-$22.4K
- BCV Asset ManagementSold out · -10,000 sh-$5.6K
- Vontobel Holding Ltd.Trimmed · -7,811 sh-$4.4K
LEXX 13F holders ranked 1–31 of 31
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Invenomic Capital Management#1 · 345,685 sh | 345,685 | $193.6K | 0.01% | -21.8% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 298,436 sh | 298,436 | $167.1K | 0.00% | +34.3% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 250,415 sh | 250,415 | $140.3K | 0.00% | -14.9% |
| 4 | CITADEL ADVISORS#4 · 156,945 sh | 156,945 | $87.9K | 0.00% | +1061.4% |
| 5 | TORONTO DOMINION BANK#5 · 100,013 sh | 100,013 | $56.1K | <0.01% | -28.6% |
| 6 | VANGUARD FIDUCIARY#6 · 94,166 sh | 94,166 | $52.7K | 0.00% | 0.0% |
| 7 | HRT FINANCIAL#7 · 65,049 sh | 65,049 | $36.0K | <0.01% | +252.3% |
| 8 | UBS Group AG#8 · 46,966 sh | 46,966 | $26.3K | 0.00% | -10.9% |
| 9 | NORTHERN#9 · 39,825 sh | 39,825 | $22.3K | 0.00% | +116.6% |
| 10 | STATE STREET#10 · 39,301 sh | 39,301 | $22.0K | 0.00% | 0.0% |
| 11 | StoneX Group#11 · 25,714 sh | 25,714 | $15.5K | <0.01% | New |
| 12 | BlackRock#12 · 27,445 sh | 27,445 | $15.4K | 0.00% | 0.0% |
| 13 | Krilogy Financial#13 · 24,153 sh | 24,153 | $13.5K | — | +22.9% |
| 14 | XTX Topco Ltd#14 · 22,298 sh | 22,298 | $12.5K | <0.01% | -11.0% |
| 15 | Virtu Financial#15 · 18,901 sh | 18,901 | $11.0K | <0.01% | New |
| 16 | RENAISSANCE TECHNOLOGIES#16 · 16,500 sh | 16,500 | $9.2K | 0.00% | +1.2% |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#17 · 15,263 sh | 15,263 | $8.5K | 0.00% | New |
| 18 | Vontobel Holding Ltd.#18 · 15,189 sh | 15,189 | $8.5K | — | -34.0% |
| 19 | BANK OF MONTREAL#19 · 14,033 sh | 14,033 | $7.9K | 0.00% | 0.0% |
| 20 | Vanguard Global Advisers#20 · 10,204 sh | 10,204 | $5.7K | 0.00% | 0.0% |
| 21 | ROYAL BANK OF CANADA#21 · 7,159 sh | 7,159 | $4.0K | 0.00% | +0.3% |
| 22 | Crews Bank#22 · 3,864 sh | 3,864 | $2.2K | <0.01% | New |
| 23 | OSAIC#23 · 2,195 sh | 2,195 | $1.2K | 0.00% | +262.8% |
| 24 | Federation des caisses Desjardins du Quebec#24 · 382 sh | 382 | $214.00 | 0.00% | 0.0% |
| 25 | FMR#25 · 213 sh | 213 | $119.00 | 0.00% | New |
| 26 | Farther Finance Advisors#26 · 172 sh | 172 | $96.00 | — | +3.6% |
| 27 | Tower Research Capital (TRC)#27 · 152 sh | 152 | $85.00 | 0.00% | +7500.0% |
| 28 | BARCLAYS PLC#28 · 92 sh | 92 | $52.00 | 0.00% | New |
| 29 | GABLES CAPITAL MANAGEMENT#29 · 13 sh | 13 | $7.00 | 0.00% | 0.0% |
| 30 | MORGAN STANLEY#30 · 3 sh | 3 | $2.00 | 0.00% | 0.0% |
| 31 | SBI Securities , Ltd.#31 · 1 sh | 1 | $1.00 | — | 0.0% |
Funds that sold out of LEXX in Q2 2026 (3)
Held LEXX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| BCV Asset Management10,000 sh | 10,000 | $7.8K |
| Byrne Asset Management800 sh | 800 | $624.00 |
| CITIGROUP489 sh | 489 | $381.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.